Live from the NIH registry
Studies recruiting near Louisville right now
Top 25 of 562 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Jewish Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Myelodysplastic Syndrome, Acute Myeloid Leukemia
Phase 1
Interventional 178 participants sought
Norton Hospitals, Inc — Louisville, Kentucky (8.6 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
The James Graham Brown Cancer Center at University of Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: NRG Oncology
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Baptist Health - Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
University of Louisville Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: Hoffmann-La Roche
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Louisville, KY — Louisville, Kentucky (8.6 mi)
· Sponsor: Mediar Therapeutics
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Louisville, Kentucky (8.6 mi)
· Sponsor: Enveda Therapeutics
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Gastroenterology Health Partners — Louisville, Kentucky (8.6 mi)
· Sponsor: Eli Lilly and Company
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Jewish Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: SWOG Cancer Research Network
Complex Adult Deformity Surgery (CADS)
Adult Spinal Deformity, Scoliosis
N/A
Observational 1,500 participants sought
Norton Leatherman Spine Center — Louisville, Kentucky (8.6 mi)
· Sponsor: International Spine Study Group Foundation
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
Jewish Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Norton Children's Hospital — Louisville, Kentucky (8.6 mi)
· Sponsor: Children's Oncology Group
Supporting Resilience Among Re-entered Seniors
Chronic Disease
N/A
Interventional 8 participants sought
New Legacy Reentry — Louisville, Kentucky (8.6 mi)
· Sponsor: University of Louisville
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Louisville, Kentucky (8.6 mi)
· Sponsor: TG Therapeutics, Inc.
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
University of Louisville Physicians — Louisville, Kentucky (8.6 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
DelRicht Clinical Research - Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: Ardelyx
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Phase 2
Interventional 500 participants sought
Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine — Louisville, Kentucky (8.6 mi)
· Sponsor: Giselle Sholler
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
James Graham Brown Cancer Center ( Site 0058) — Louisville, Kentucky (8.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Harnessing Neuroplasticity to Enhance Functional Recovery During Chronic Recovery From Upper Extremity Nerve Repair
Hand Transplantation, Peripheral Nerve Injuries
N/A
Interventional 180 participants sought
Christine Kleinert Institute for Hand & Microsurgery — Louisville, Kentucky (8.6 mi)
· Sponsor: University of Missouri-Columbia
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
University of Louisville — Louisville, Kentucky (8.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Norton Hospital Pavilion and Medical Campus — Louisville, Kentucky (8.6 mi)
· Sponsor: NRG Oncology
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10086, Louisville, Kentucky — Louisville, Kentucky (8.6 mi)
· Sponsor: Colorado Prevention Center
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Phase 4
Interventional 300 participants sought
Lake Cumberland Rheumatology — New Albany, Indiana (12.6 mi)
· Sponsor: Amgen
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50586 — Louisville, Kentucky (8.6 mi)
· Sponsor: UCB Biopharma SRL
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
CommonSpirit Saint Joseph Hospital - Bardstown — Bardstown, Kentucky (26.6 mi)
· Sponsor: NRG Oncology